CytomX Therapeutics, Inc. (CTMX)
2.765
+0.08
(+2.79%)
USD |
NASDAQ |
Sep 16, 16:00
2.765
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price : 2.765 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 2.72 | 2.865 | 2.671 | 2.765 | 6.869M |
| Sep 15, 2026 | 3.20 | 3.205 | 2.665 | 2.69 | 7.510M |
| Sep 14, 2026 | 3.335 | 3.36 | 3.145 | 3.20 | 6.139M |
| Sep 11, 2026 | 3.38 | 3.406 | 3.23 | 3.29 | 2.250M |
| Sep 10, 2026 | 3.50 | 3.52 | 3.335 | 3.35 | 2.059M |
| Sep 09, 2026 | 3.66 | 3.66 | 3.495 | 3.54 | 2.054M |
| Sep 08, 2026 | 3.612 | 3.66 | 3.58 | 3.65 | 1.985M |
| Sep 04, 2026 | 3.64 | 3.725 | 3.53 | 3.71 | 2.298M |
| Sep 03, 2026 | 3.73 | 3.82 | 3.61 | 3.68 | 2.558M |
| Sep 02, 2026 | 3.72 | 3.885 | 3.69 | 3.72 | 6.497M |
| Sep 01, 2026 | 3.32 | 3.73 | 3.32 | 3.67 | 8.821M |
| Aug 31, 2026 | 3.20 | 3.375 | 3.17 | 3.36 | 2.381M |
| Aug 28, 2026 | 3.40 | 3.42 | 3.21 | 3.21 | 2.174M |
| Aug 27, 2026 | 3.455 | 3.52 | 3.285 | 3.42 | 2.583M |
| Aug 26, 2026 | 3.35 | 3.38 | 3.285 | 3.32 | 2.216M |
| Aug 25, 2026 | 3.32 | 3.445 | 3.32 | 3.37 | 4.027M |
| Aug 24, 2026 | 3.30 | 3.38 | 3.175 | 3.29 | 3.192M |
| Aug 21, 2026 | 3.31 | 3.415 | 3.27 | 3.28 | 2.895M |
| Aug 20, 2026 | 3.53 | 3.560 | 3.27 | 3.29 | 2.605M |
| Aug 19, 2026 | 3.48 | 3.60 | 3.46 | 3.57 | 4.579M |
| Aug 18, 2026 | 3.41 | 3.435 | 3.30 | 3.39 | 2.457M |
| Aug 17, 2026 | 3.36 | 3.46 | 3.34 | 3.45 | 2.365M |
| Aug 14, 2026 | 3.34 | 3.385 | 3.28 | 3.36 | 1.433M |
| Aug 13, 2026 | 3.50 | 3.50 | 3.34 | 3.35 | 1.809M |
| Aug 12, 2026 | 3.48 | 3.535 | 3.415 | 3.49 | 2.519M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 774.61 |
| ACADIA Pharmaceuticals, Inc. | 27.54 |
| Alnylam Pharmaceuticals, Inc. | 239.36 |
| Anika Therapeutics, Inc. | 20.84 |
| Savara, Inc. | 5.13 |
Price Related Metrics
| PS Ratio | 27.62 |
| Price to Book Value | 1.995 |
| Earnings Yield | -16.52% |
| Market Cap | 602.49M |